Clinical Efficacy of Etanercept in Patients with Rheumatoid Arthritis and its Associated Diseases
Not Applicable
Recruiting
- Conditions
- Rheumatoid arthritis
- Registration Number
- JPRN-UMIN000013368
- Lead Sponsor
- Osaka Medical College
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
Rheumatoid arthritis patients with severe pulmonary, renal or cardiac disorders
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The therapeutic effects and adverse events 52 weeks after the initiation of etanercept
- Secondary Outcome Measures
Name Time Method